Insights from 2023 SABCS


 

SABCS 2023 Insights: "ELEVATE Study Evaluating Elacestrant in Various Combinations in Patients With ER+, HER2- Locally Advanced or mBC"

142 views
December 15, 2023
Comments 0
Login to view comments. Click here to Login